HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

计划入组 122 人 · 首次发布于 2015 年 5 月 7 日

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

计划入组 270 人 · 首次发布于 2016 年 5 月 25 日

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

计划入组 17 人 · 首次发布于 2017 年 11 月 28 日

anti-HERV-K therapy

HERV Targeted TCR-T(Immunoscape)

anti-HERV-W humanized monoclonal antibodies (diabetes)

Hervor Therapeutics

China

Herc Holdings

Innate Pharma

France

HERVolution Therapeutics Secures $11.7 Million Series A to Advance HERV-Targeted Immunotherapies

GeNeuro Wins European Patent for GNK-301, an Anti-HERV K Antibody Targeting ALS

ErVimmune Raises €17 Million to Advance Off-the-Shelf Cancer Vaccine Targeting Human Endogenous Retroviruses